Last reviewed · How we verify
Tacrolimus, Pancea Biotech Limited — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
Tacrolimus, Pancea Biotech Limited (Tacrolimus, Pancea Biotech Limited) — University of Cincinnati.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Tacrolimus, Pancea Biotech Limited TARGET | Tacrolimus, Pancea Biotech Limited | University of Cincinnati | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Tacrolimus, Pancea Biotech Limited CI watch — RSS
- Tacrolimus, Pancea Biotech Limited CI watch — Atom
- Tacrolimus, Pancea Biotech Limited CI watch — JSON
- Tacrolimus, Pancea Biotech Limited alone — RSS
Cite this brief
Drug Landscape (2026). Tacrolimus, Pancea Biotech Limited — Competitive Intelligence Brief. https://druglandscape.com/ci/tacrolimus-pancea-biotech-limited. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab